5 Ongoing Clinical Trials Evaluating Treatment for MS

by palligoelme@gmail.com | Mar 14, 2025 | Clinical Trials

​  National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by MS Focus: the Multiple Sclerosis Foundation and affiliated groups.  National MS Education and Awareness Month is celebrated each year in the...

SRC approves opening of TransCode’s fourth cohort in trial of TTX-MC138

by palligoelme@gmail.com | Mar 14, 2025 | Clinical Trials

​  The SRC has granted unanimous approval for TransCode to open the fourth cohort in its Phase I trial of TTX-MC138.  The SRC has granted unanimous approval for TransCode to open the fourth cohort in its Phase I trial of TTX-MC138. 

Vir enrols first subject in Phase III programme to assess CHD therapy

by palligoelme@gmail.com | Mar 14, 2025 | Clinical Trials

​  Vir Biotechnology has enrolled the first subject in the Phase III ECLIPSE registrational programme of tobevibart plus elebsiran.  Vir Biotechnology has enrolled the first subject in the Phase III ECLIPSE registrational programme of tobevibart plus...

Thailand to kick off clinical trials for dengue vaccine in April

by palligoelme@gmail.com | Mar 14, 2025 | Clinical Trials

​  The study, involving 35,000 participants, aims to assess the vaccine’s effectiveness, and if successful, it could be included in the universal healthcare system  The study, involving 35,000 participants, aims to assess the vaccine’s effectiveness, and if...

Solving The Protocol Deviation Puzzle With FDA Draft Guidance

by palligoelme@gmail.com | Mar 14, 2025 | Clinical Trials

​  Knowing exactly what to do when a protocol deviation (PD) arises can be challenging. Here, consultant Leila Cupersmith summarizes new FDA guidance on managing PDs.  Knowing exactly what to do when a protocol deviation (PD) arises can be challenging. Here,...